Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/30480
Appears in Collections:Management, Work and Organisation Journal Articles
Peer Review Status: Refereed
Title: Research and development spending and technical efficiency: evidence from biotechnology and pharmaceutical sector
Author(s): Grant, Kevin
Matousek, Roman
Meyer, Martin
Tzeremes, Nickolaos G.
Contact Email: kevin.grant@stir.ac.uk
Keywords: R&D efficiency
technology
innovation
data envelopment analysis
US biotechnology and pharmaceutical firms
Issue Date: 30-Sep-2019
Citation: Grant K, Matousek R, Meyer M & Tzeremes NG (2019) Research and development spending and technical efficiency: evidence from biotechnology and pharmaceutical sector. International Journal of Production Research p. 15. https://doi.org/10.1080/00207543.2019.1671623
Abstract: Set within the expenditure context of the global financial crisis (GFC), this paper explores how the research and development (R&D) expenditures of biotechnology and pharmaceutical companies affect their technical efficiency levels. A balanced panel of 149 US firms operating in the biotechnology and pharmaceutical sector (covering the period 2000–2017) was employed. Output-oriented partial frontier measures were used to measure the effect of R&D expenditure on firms’ technical efficiency levels. Findings suggest that company efficiency is an important contributor on the effects of R&D on productivity and efficiency. Result suggests that a relationship between technical efficiency and R&D expenditure exhibits a ‘U’-shape relationship. The estimated efficiency of biotechnology firms is higher compared to pharmaceutical firms driven by their higher R&D expenditure levels. We demonstrate that R&D expenditures are essential for firm efficiency. We posit that a threshold level for achieving optimal efficiency levels exist, which can be used to inform managerial and policy-making decisions at the firm level.
DOI Link: 10.1080/00207543.2019.1671623
Rights: [Grant-etal_InJrnlProdResearch_v12_R_R1_Oct_2018.pdf] This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. This is an Accepted Manuscript of an article published by Taylor & Francis Group in International Journal of Production Research on 30 Sep 2019, available online: http://www.tandfonline.com/10.1080/00207543.2019.1671623.
[Research and development spending and technical efficiency evidence from biotechnology and pharmaceutical sector.pdf] The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.
Notes: Output Status: Forthcoming/Available Online

Files in This Item:
File Description SizeFormat 
Research and development spending and technical efficiency evidence from biotechnology and pharmaceutical sector.pdfFulltext - Published Version1.73 MBAdobe PDFUnder Permanent Embargo    Request a copy
Grant-etal_InJrnlProdResearch_v12_R_R1_Oct_2018.pdfFulltext - Accepted Version1.02 MBAdobe PDFUnder Embargo until 2020-10-01    Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.